In this large contemporary, prospective transcatheter aortic valve replacement registry, oral anticoagulation appears to be protective against valve degeneration but is associated with increased mortality. The strongest predictors of mortality at three years were male gender, renal failure, and atrial fibrillation.
ABSTRACT & COMMENTARY
Study Adds Complexity to Post-TAVR Anticoagulation
December 1, 2018